Search Results - "Schacht, G E"

  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    Treatment of psoriasis with long-term administration of somatostatin analog 201-995

    Treatment of psoriasis with long-term administration of somatostatin analog 201-995 by Camisa, C, Maceyko, R F, O'Dorisio, T M, Schacht, G E, Mekhjian, H S

    Get more information
    Journal Article
    Save to List
    Saved in:
  2. 2
    Treatment of psoriasis with chronic subcutaneous administration of somatostatin analog 201-995 (sandostatin). I. An open-label pilot study

    Treatment of psoriasis with chronic subcutaneous administration of somatostatin analog 201-995 (sandostatin). I. An open-label pilot study by Camisa, C, O'Dorisio, T M, Maceyko, R F, Schacht, G E, Mekhjian, H S, Howe, B A

    Published in Cleveland Clinic journal of medicine (01-01-1990)
    “…Increased levels of human growth hormone (HGH) may correlate with the severity of psoriasis and native somatostatin (SRIF) may improve it by inhibiting HGH…”
    Get more information
    Journal Article
    Save to List
    Saved in:
  3. 3
    Treatment of psoriasis with chronic subcutaneous administration of somatostatin analog 201-995 (sandostatin). II. Effect on pancreatic and thyroid hormone

    Treatment of psoriasis with chronic subcutaneous administration of somatostatin analog 201-995 (sandostatin). II. Effect on pancreatic and thyroid hormone by Camisa, C, Schacht, G E, O'Dorisio, T M, Maceyko, R F

    Published in Cleveland Clinic journal of medicine (01-01-1990)
    “…Nine patients with psoriasis vulgaris were treated for 12 weeks with somatostatin analog, octreotide acetate (SMS 201-995) 50 or 100 micrograms by subcutaneous…”
    Get more information
    Journal Article
    Save to List
    Saved in:

Search Tools: